Search results: Sage Journals

Open accessCase reportFirst published June, 2023

L858R-K860I Doublet Mutation of EGFR gene in Non-Small Cell Lung Carcinoma: Cause of a False Negative Call for L858R on Initial Companion Diagnostic Test

Anurag Mehta, Himanshi Diwan, Shrinidhi Nathany [...]

Journal of Current Oncology

Open accessResearch articleFirst published 2025

Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED)

Masashi Ishihara, Takahisa Kawamura, Yukiko Namba [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published May, 2025

Molecular Testing for EGFR Mutation in Moroccan NSCLC Patients: CHU Hassan II-Fez Experience

Sara Boukansa, Ismail Mouhrach, Fatima El Agy [...]

International Journal of Surgical Pathology

Open accessResearch articleFirst published 2019

Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell–Bearing Mice

Hwa Jeong Kang, Jeehye Kim, Seong Hyeok Cho [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published December, 2020

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases

Mingming Hu, Tongmei Zhang, Yuan Yang [...]

The International Journal of Biological Markers

Restricted accessReview articleFirst published June, 2016

Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

Clement Chung

Journal of Oncology Pharmacy Practice

Restricted accessCase reportFirst published April, 2022

Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858R

Matthew J. Hadfield, Alla Turshudzhyan, Khalid Shalaby [...]

Journal of Oncology Pharmacy Practice

Open accessCase reportFirst published 2025

A rare epidermal growth factor receptor T790M/cis-C797S/L718Q compound mutation in a lung adenocarcinoma patient who did not derive any benefit from combination therapy with afatinib and bevacizumab

Xiaopeng Meng, Jingyi Liu, Xiaohui Wu [...]

Sage Open Medical Case Reports

Open accessCase reportFirst published 2021

A case of advanced adenocarcinoma genetically confirmed with EGFR/BRAF co-mutation in both primary and metastatic lesions

Kei Morikawa, Masahiro Iinuma, Yusuke Shinozaki [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published December, 2018

Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

Min Yu, Qian Zhao, Yanying Li [...]

Cancer Biotherapy and Radiopharmaceuticals

Open accessCase reportFirst published June, 2023

L858R-K860I Doublet Mutation of EGFR gene in Non-Small Cell Lung Carcinoma: Cause of a False Negative Call for L858R on Initial Companion Diagnostic Test

Anurag Mehta, Himanshi Diwan, Shrinidhi Nathany [...]

Journal of Current Oncology

Open accessResearch articleFirst published 2025

Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED)

Masashi Ishihara, Takahisa Kawamura, Yukiko Namba [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published May, 2025

Molecular Testing for EGFR Mutation in Moroccan NSCLC Patients: CHU Hassan II-Fez Experience

Sara Boukansa, Ismail Mouhrach, Fatima El Agy [...]

International Journal of Surgical Pathology

Open accessResearch articleFirst published 2019

Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell–Bearing Mice

Hwa Jeong Kang, Jeehye Kim, Seong Hyeok Cho [...]

Integrative Cancer Therapies

Open accessResearch articleFirst published December, 2020

Driver gene alterations in lung adenocarcinoma: Demographic features of 2544 Chinese cases

Mingming Hu, Tongmei Zhang, Yuan Yang [...]

The International Journal of Biological Markers

Restricted accessReview articleFirst published June, 2016

Tyrosine kinase inhibitors for epidermal growth factor receptor gene mutation–positive non-small cell lung cancers: an update for recent advances in therapeutics

Clement Chung

Journal of Oncology Pharmacy Practice

Restricted accessCase reportFirst published April, 2022

Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858R

Matthew J. Hadfield, Alla Turshudzhyan, Khalid Shalaby [...]

Journal of Oncology Pharmacy Practice

Open accessCase reportFirst published 2025

A rare epidermal growth factor receptor T790M/cis-C797S/L718Q compound mutation in a lung adenocarcinoma patient who did not derive any benefit from combination therapy with afatinib and bevacizumab

Xiaopeng Meng, Jingyi Liu, Xiaohui Wu [...]

Sage Open Medical Case Reports

Open accessCase reportFirst published 2021

A case of advanced adenocarcinoma genetically confirmed with EGFR/BRAF co-mutation in both primary and metastatic lesions

Kei Morikawa, Masahiro Iinuma, Yusuke Shinozaki [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published December, 2018

Progression of Central Nervous System Metastases in Advanced Nonsmall Cell Lung Cancer Patients Effectively Treated with First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor

Min Yu, Qian Zhao, Yanying Li [...]

Cancer Biotherapy and Radiopharmaceuticals